141 filings
Page 5 of 8
8-K
ficut
26 Oct 20
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
4:04pm
424B5
fqtnbde8
26 Oct 20
Prospectus supplement for primary offering
4:01pm
10-K/A
0pzv6dc
23 Oct 20
Annual report (amended)
4:02pm
S-3MEF
czto0
22 Oct 20
Registration of additional securities for an S-3
9:57pm
424B5
40swokwins2cwoj
22 Oct 20
Prospectus supplement for primary offering
4:28pm
8-K
r4mg0w
22 Sep 20
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
7:30am
UPLOAD
bbtn4 lg8kw4z62qx
27 Aug 20
Letter from SEC
12:00am
8-K
lbc r5t56dht
29 Jul 20
Entry into a Material Definitive Agreement
6:06am
424B5
k1uj lm91rq8z9f
29 Jul 20
Prospectus supplement for primary offering
6:03am
8-K
g840o ggv4
23 Jul 20
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
7:05am
EFFECT
54krvuu0uf h1eopj6fk
7 Jul 20
Notice of effectiveness
12:15am
CORRESP
3ynu5 2dhhu0du
1 Jul 20
Correspondence with SEC
12:00am
UPLOAD
10yqy mhcde
25 Jun 20
Letter from SEC
12:00am
S-3
pxksp3 c6nc
19 Jun 20
Shelf registration
4:54pm
8-K
bot57lnq6
9 Jun 20
Departure of Directors or Certain Officers
12:00am
DEFA14A
2osclw8cxg
5 May 20
Additional proxy soliciting materials
5:05pm